# A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum

> **NCT05569252** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 65 (actual)

## Conditions studied

- Pseudoxanthoma Elasticum

## Interventions

- **DRUG:** DS-1211b
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05569252
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-20
- **Primary completion:** 2023-11-21
- **Final completion:** 2023-11-21
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2024-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05569252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05569252, "A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05569252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*